Correlation Between NYSE Composite and Theriva Biologics
Can any of the company-specific risk be diversified away by investing in both NYSE Composite and Theriva Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NYSE Composite and Theriva Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between NYSE Composite and Theriva Biologics, you can compare the effects of market volatilities on NYSE Composite and Theriva Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NYSE Composite with a short position of Theriva Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of NYSE Composite and Theriva Biologics.
Diversification Opportunities for NYSE Composite and Theriva Biologics
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between NYSE and Theriva is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding NYSE Composite and Theriva Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Theriva Biologics and NYSE Composite is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NYSE Composite are associated (or correlated) with Theriva Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Theriva Biologics has no effect on the direction of NYSE Composite i.e., NYSE Composite and Theriva Biologics go up and down completely randomly.
Pair Corralation between NYSE Composite and Theriva Biologics
Assuming the 90 days trading horizon NYSE Composite is expected to generate 1.76 times less return on investment than Theriva Biologics. But when comparing it to its historical volatility, NYSE Composite is 17.65 times less risky than Theriva Biologics. It trades about 0.42 of its potential returns per unit of risk. Theriva Biologics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 146.00 in Theriva Biologics on September 1, 2024 and sell it today you would lose (2.00) from holding Theriva Biologics or give up 1.37% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
NYSE Composite vs. Theriva Biologics
Performance |
| Timeline |
NYSE Composite and Theriva Biologics Volatility Contrast
Predicted Return Density |
| Returns |
NYSE Composite
Pair trading matchups for NYSE Composite
Theriva Biologics
Pair trading matchups for Theriva Biologics
Pair Trading with NYSE Composite and Theriva Biologics
The main advantage of trading using opposite NYSE Composite and Theriva Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NYSE Composite position performs unexpectedly, Theriva Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theriva Biologics will offset losses from the drop in Theriva Biologics' long position.| NYSE Composite vs. Acumen Pharmaceuticals | NYSE Composite vs. Mind Medicine | NYSE Composite vs. NL Industries | NYSE Composite vs. Ecovyst |
| Theriva Biologics vs. Tff Pharmaceuticals | Theriva Biologics vs. Eliem Therapeutics | Theriva Biologics vs. Inhibrx | Theriva Biologics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |